ASK REDCHAT ANYTHING ABOUT CALCIMEDICA INC.
CalciMedica Inc. (NASDAQ: CALC)
Listen to this Section
$0.99
+0.1390
(
+16.34% )
2.3M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Auxora™DetailsAcute Pancreatitis |
Phase 2b |
| Auxora™DetailsAsparaginase-induced pancreatic toxicity |
Phase 2 |
| Auxora™DetailsAcute Kidney Injury, Kidney disease |
Phase 2 |
| GB-102 (Pan-VEGF inhibitor)DetailsEye disease , Wet age-related macular degeneration , Age-related macular degeneration |
Failed |
| GB-102 (Pan-VEGF inhibitor)DetailsDiabetes, Eye disease , Diabetic macular edema |
Failed |
Market Data
|
| Open |
$0.99 |
| Previous Close |
$0.85 |
| Volume |
2.3M |
| Market Cap |
$13.43M |
| Day Range |
$0.85 - $1.11 |
| 52 Week Range |
$0.46 - $7.20 |
| Shares Outstanding |
15.80M |
| Change % |
+16.34% |
| Net Change |
▲ 0.1390 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-376,293.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-06-13 |
Buy |
5000.00 |
Roberts Eric W |
| 2025-06-09 |
Buy |
5100.00 |
Roberts Eric W |
| 2025-06-03 |
Buy |
1000.00 |
Bardin Stephen |
| 2024-12-06 |
Buy |
4800.00 |
MIDDLETON FRED A |
| 2024-11-05 |
Buy |
86867.00 |
Sanderling Venture Partners VI Co Investment Fund LP |
| 2024-11-05 |
Buy |
20000.00 |
MIDDLETON FRED A |
| 2024-11-01 |
Buy |
20000.00 |
Leheny A. Rachel |
| 2024-11-01 |
Buy |
53333.00 |
Roberts Eric W |
| 2024-11-01 |
Buy |
53333.00 |
WILSON ROBERT N |
| 2024-08-27 |
Buy |
1000.00 |
Leheny A. Rachel |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 4 |
Insider transactions |
1 |
Apr 07, 2026 |
| 8-k |
8K-related |
11 |
Mar 18, 2026 |
| 8-k |
8K-related |
12 |
Mar 03, 2026 |
| 10-k |
Annual reports |
102 |
Mar 03, 2026 |
| s-3 |
Registration statements |
20 |
Mar 03, 2026 |